NICE Initiative Aims to Speed Up Adoption of Innovative Health Technologies
The National Institute for Health and Care Excellence (NICE) has launched an initiative to speed up the adoption of innovative health technologies through the NHS. The institute is introducing a new service – the Office for Market Access (OMA).
The OMA will give pharmaceutical and medical device companies access to a dedicated team at NICE that they can approach with enquires relating to health technology evaluation. It will also be able to use established relationships with regulators, research organisations, NHS organisations and government departments to facilitate beneficial interactions with the right people.
This assistance will help to prevent problems which often come up once a technology appraisal is already underway, and will make the health technology evaluation process move more quickly and efficiently.
“OMA will help to improve the rates at which drugs, devices and diagnostics get picked up and adopted by the NHS,” says Professor Carole Longson, NICE health technology and evaluation centre director. “It will speed up the adoption of innovative and cost-effective health technologies by helping companies to get the right evidence, develop a better business case and engage with the right people.”
The Association of the British Pharmaceutical Industry has welcomed the initiative, noting that it presents a good opportunity for “all key stakeholders that play a role in getting new medicines to patients, to engage and interact together more closely.”
“Technology continues to transform our ability to predict, diagnose and treat disease,” says Professor Longson. “New drugs and technologies – many developed here in the UK with our superb science base – are helping to turn conditions that used to disable or kill people into chronic illnesses. NICE can encourage the faster development and delivery of new, effective, innovative and affordable drugs and technologies to patients.”